Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Rutgers to Host Biopharma, Health Care Innovation Leaders at North American Summit July 21-22

New Brunswick, NJ, July 15, 2014 — Rutgers, The State University of New Jersey will host the influential TTS Global Initiative’s North American Summit on July 21-22 at Rutgers’ Busch Campus in Piscataway, NJ.

The North American Summit is an annual meeting of top biotech VCs, bankers, biopharmaceutical and health care executives, technology-transfer and licensing directors with universities and institutes, biotech CEOs, and other key stakeholders in early-stage biotech and health care.

The event will offer participants the opportunity to network with peers and discuss the key issues, challenges, and opportunities facing all stakeholders in biopharma and health care innovation.

The North American Summit, part of the TTS Global Initiative, moves back to the Eastern Seaboard having previously been in the MaRS Discovery District, Toronto; at NIH in Bethesda, MD; John Hopkins, Maryland; and UCSF, San Francisco.

The Summit is deliberately compact and exclusive drawing a maximum of 300 attendees from across America and Canada, as well as a global audience including attendees from Europe, Asia and Australia.

All attendees/members are entitled to access and utilize the TTS Innovation Bank an online repository for posting and sharing technological innovation.

Attendees from each of the four Summits that make up the TTS Global Initiative are able to interact with innovators, entrepreneurs, biotech, pharma, VC for collaboration, partnering and licensing opportunities.

Founded in 2007, the TTS Global Initiative is the premier international think tank and platform bringing together key opinion leaders from all of the critical stakeholders involved in biomedical sector health care technology transfer, broadly defined.

The TTS Global Initiative has one primary objective: to foster innovation in health care by accelerating the translation of world-class life sciences and biomedical research from the lab to the patient and the market.

To access the event program, click here.

For additional information about the July 21-22 event or to register, click here.